We are live on
!
Find out more
AIC
Argus Investors Counsel Portfolio holdings
AUM
$130M
1-Year Est. Return
37.06%
This Fund
S&P 500
This Quarter
Est. Return
+8.1%
1 Year Est. Return
+37.06%
3 Year Est. Return
+123.69%
5 Year Est. Return
+149.89%
10 Year Est. Return
+466.25%
AUM
$246M
AUM Growth
-$1.69M
(-0.68%)
Cap. Flow
-$19.3M
Cap. Flow
% of AUM
-7.87%
Top 10 Holdings %
Top 10 Hldgs %
23.59%
Holding
94
New
9
Increased
23
Reduced
50
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
S&P Global
SPGI
|
+$769K |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$545K |
| 3 |
UnitedHealth
UNH
|
+$353K |
| 4 |
Allstate
ALL
|
+$326K |
| 5 |
Nasdaq
NDAQ
|
+$323K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nucor
NUE
|
+$2.49M |
| 2 |
NVIDIA
NVDA
|
+$1.26M |
| 3 |
Blackrock
BLK
|
+$1.13M |
| 4 |
Corning
GLW
|
+$737K |
| 5 |
Texas Instruments
TXN
|
+$707K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.17% |
| 2 | Financials | 15.73% |
| 3 | Healthcare | 13.78% |
| 4 | Industrials | 11.95% |
| 5 | Consumer Staples | 10.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Eli Lilly
LLY
$1.1T
| $1.61M | 0.66% |
7,037
+741
| +12% | +$149K |
|
52
Bio-Techne
TECH
$11.2B
| $1.38M | 0.56% |
12,236
+388
| +3% | +$40.8K |
|
53
Deere & Co
DE
$164B
| $1.34M | 0.54% |
3,787
+60
| +2% | +$21.9K |
|
54
Old Dominion Freight Line
ODFL
$44.1B
| $1.21M | 0.49% |
9,534
+1,546
| +19% | +$198K |
|
55
Autodesk
ADSK
$54.1B
| $1.2M | 0.49% |
4,115
+145
| +4% | +$41.4K |
|
56
Thermo Fisher Scientific
TMO
$222B
| $1.15M | 0.47% |
2,286
-204
| -8% | -$96.3K |
|
57
Meta Platforms (Facebook)
META
$1.52T
| $1.13M | 0.46% |
3,252
+137
| +4% | +$44K |
|
|
58
Allstate
ALL
$68.2B
| $1.13M | 0.46% |
8,649
+2,526
| +41% | +$326K |
|
59
Analog Devices
ADI
$187B
| $1.11M | 0.45% |
6,465
+184
| +3% | +$29.5K |
|
|
60
S&P Global
SPGI
$121B
| $1.1M | 0.45% |
2,680
+2,002
| +295% | +$769K |
|
61
PNC Financial Services
PNC
$100B
| $1.04M | 0.42% |
5,466
+118
| +2% | +$22.1K |
|
|
CTLT
62
DELISTED
CATALENT, INC.
CTLT
| $948K | 0.39% |
8,766
+231
| +3% | +$24.8K |
|
63
ServiceNow
NOW
$132B
| $934K | 0.38% |
8,500
+235
| +3% | +$23.8K |
|
64
iShares Russell 1000 Growth ETF
IWF
$127B
| $915K | 0.37% |
13,480
-24
| -0.2% | -$1.55K |
|
65
Cummins
CMI
$87.4B
| $854K | 0.35% |
3,503
+183
| +6% | +$46.8K |
|
66
iShares Core US Aggregate Bond ETF
AGG
$137B
| $842K | 0.34% |
7,300
| – | – |
|
67
Intercontinental Exchange
ICE
$84.5B
| $793K | 0.32% |
6,679
+310
| +5% | +$35.7K |
|
68
Ecolab
ECL
$79.7B
| $712K | 0.29% |
3,458
+135
| +4% | +$29.3K |
|
|
FISV
69
Fiserv Inc
FISV
$27.8B
| $637K | 0.26% |
5,964
+347
| +6% | +$40.3K |
|
70
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$67.5B
| $618K | 0.25% |
6,503
| – | – |
|
71
Invesco Preferred ETF
PGX
$3.76B
| $569K | 0.23% |
37,165
| – | – |
|
72
iShares MBS ETF
MBB
$38.9B
| $549K | 0.22% |
5,072
| – | – |
|
73
Vanguard Short-Term Bond ETF
BSV
$45.6B
| $473K | 0.19% |
5,756
| – | – |
|
74
iShares Russell 2000 ETF
IWM
$81.5B
| $446K | 0.18% |
1,945
-1
| -0.1% | -$225 |
|
75
Danaher
DHR
$147B
| $395K | 0.16% |
1,659
+637
| +62% | +$141K |
|
Similar funds
NCM
CG
EPCA
WM
BM
EPI
OIM
ECP
Argus Investors Counsel's Q2 2021 Portfolio in Review
As of Q2 2021, Argus Investors Counsel held 94 positions worth $246M, down 0.68% from $248M the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Argus Investors Counsel withdrew a net $19.3M in Q2 2021, closing 2 positions and reducing 50 holdings. Its most notable exit was Emergent Biosolutions, an estimated $661K position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Argus Investors Counsel opened a new position in UnitedHealth worth $355K.
- Argus Investors Counsel's largest Q2 2021 buy was UnitedHealth: 886 shares worth $355K.
- Argus Investors Counsel added most to S&P Global in Q2 2021, an estimated $769K increase.
- Argus Investors Counsel's biggest Q2 2021 reduction was Nucor, cutting an estimated $2.49M.
- Argus Investors Counsel fully exited Emergent Biosolutions in Q2 2021, selling an estimated $661K.
- Argus Investors Counsel's ten largest holdings make up 24% of its $246M portfolio in Q2 2021.
- Argus Investors Counsel opened 9 new positions and closed 2 in Q2 2021.
- Argus Investors Counsel's portfolio value fell 0.68% quarter-over-quarter to $246M.
Based on Argus Investors Counsel's 13F filing for Q2 2021, filed 30 Jul 2021.